CN101248180B - 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排 - Google Patents

作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排 Download PDF

Info

Publication number
CN101248180B
CN101248180B CN2006800219031A CN200680021903A CN101248180B CN 101248180 B CN101248180 B CN 101248180B CN 2006800219031 A CN2006800219031 A CN 2006800219031A CN 200680021903 A CN200680021903 A CN 200680021903A CN 101248180 B CN101248180 B CN 101248180B
Authority
CN
China
Prior art keywords
mtdna
dna
deletion
nucleic acid
mutations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006800219031A
Other languages
English (en)
Chinese (zh)
Other versions
CN101248180A (zh
Inventor
瑞安·帕尔
罗伯特·塞耶
加百利·道库博
珍妮弗·梅基
克里·鲁宾逊
安德烈娅·马格拉
布赖恩·赖古伊
安德烈·哈博特尔
马克·比尔克-马金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MDNA LIFE SCIENCES Inc
Original Assignee
Mitomics Inc
Genesis Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitomics Inc, Genesis Genomics Inc filed Critical Mitomics Inc
Priority to CN201310399746.XA priority Critical patent/CN103789405B/zh
Publication of CN101248180A publication Critical patent/CN101248180A/zh
Application granted granted Critical
Publication of CN101248180B publication Critical patent/CN101248180B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN2006800219031A 2005-04-18 2006-04-18 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排 Expired - Fee Related CN101248180B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310399746.XA CN103789405B (zh) 2005-04-18 2006-04-18 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67201605P 2005-04-18 2005-04-18
US60/672,016 2005-04-18
US72152205P 2005-09-29 2005-09-29
US60/721,522 2005-09-29
US78987206P 2006-04-07 2006-04-07
US60/789,872 2006-04-07
PCT/CA2006/000652 WO2006111029A1 (en) 2005-04-18 2006-04-18 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201310399746.XA Division CN103789405B (zh) 2005-04-18 2006-04-18 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排

Publications (2)

Publication Number Publication Date
CN101248180A CN101248180A (zh) 2008-08-20
CN101248180B true CN101248180B (zh) 2013-09-25

Family

ID=37114687

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2006800219031A Expired - Fee Related CN101248180B (zh) 2005-04-18 2006-04-18 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排
CN201310399746.XA Expired - Fee Related CN103789405B (zh) 2005-04-18 2006-04-18 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201310399746.XA Expired - Fee Related CN103789405B (zh) 2005-04-18 2006-04-18 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排

Country Status (15)

Country Link
US (4) US8008008B2 (https=)
EP (2) EP1877559B1 (https=)
JP (2) JP5537804B2 (https=)
KR (1) KR101363032B1 (https=)
CN (2) CN101248180B (https=)
AT (1) ATE484589T1 (https=)
AU (1) AU2006238390B2 (https=)
CA (2) CA2606156C (https=)
DE (1) DE602006017534D1 (https=)
DK (1) DK1877559T3 (https=)
ES (1) ES2354452T3 (https=)
NZ (2) NZ587665A (https=)
PT (1) PT1877559E (https=)
SG (1) SG2014011837A (https=)
WO (1) WO2006111029A1 (https=)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101248180B (zh) * 2005-04-18 2013-09-25 米托米克斯公司 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排
US20130022979A1 (en) * 2005-04-18 2013-01-24 Genesis Genomics Inc. 3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
CN100526453C (zh) * 2005-05-20 2009-08-12 麦克奥迪实业集团有限公司 激光显微切割后细胞收集方法
AU2005333512A1 (en) * 2005-06-16 2006-12-28 Biotools Biotechnological & Medical Laboratories, S.A. Nucleic acid detection method involving the direct generation of a measurable signal
US20080254530A1 (en) * 2007-02-27 2008-10-16 Gettysburg College Isolation and characterization of a single mitochondrion
CN101874119B (zh) * 2007-09-26 2015-01-28 米托米克斯公司 3.4kb线粒体DNA缺失用于检测癌症
NZ584595A (en) * 2007-10-11 2012-12-21 Mitomics Inc Methods for assaying melanocortin 1 receptor variants utilysing a mitochondrial DNA abberration which is a 3895 bp mtDNA deletion between nucleic acid 546 to 4444 of the mtDNA genome
WO2009046514A1 (en) * 2007-10-11 2009-04-16 Genesis Genomics Inc. Methods for non-invasive collection of skin cells for dna analysis
JP5481383B2 (ja) * 2007-11-09 2014-04-23 ミトミクス インコーポレイテッド 癌の検出に使用するための、約１２３１７残基〜約１６２５４残基の間のミトコンドリアｄｎａの欠失
AU2009227935B2 (en) * 2008-03-28 2015-07-09 Mdna Life Sciences Inc. Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor
JP2012501456A (ja) * 2008-08-28 2012-01-19 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
EP2324354B1 (en) * 2008-08-29 2014-07-16 Astute Medical, Inc. Methods for prognosis of acute renal failure
CA2740923A1 (en) * 2008-10-21 2010-04-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ES2836218T3 (es) 2008-10-21 2021-06-24 Astute Medical Inc Procedimientos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal
EP2913676A1 (en) 2008-11-10 2015-09-02 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2009316387B2 (en) * 2008-11-22 2015-01-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010279249B2 (en) 2009-02-06 2015-08-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9229010B2 (en) 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010234238B2 (en) * 2009-03-27 2016-07-28 Mdna Life Sciences Inc. Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
US12129514B2 (en) 2009-04-30 2024-10-29 Molecular Loop Biosolutions, Llc Methods and compositions for evaluating genetic markers
EP2425240A4 (en) 2009-04-30 2012-12-12 Good Start Genetics Inc METHOD AND COMPOSITION FOR EVALUATING GENETIC MARKERS
AU2010315008B2 (en) 2009-11-07 2015-12-03 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2011115098A (ja) * 2009-12-04 2011-06-16 Nippon Menaade Keshohin Kk 加齢による皮膚明度の低下を予測する皮膚評価方法
WO2011075744A1 (en) 2009-12-20 2011-06-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2011213684B2 (en) 2010-02-05 2014-11-20 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ701807A (en) 2010-02-26 2015-05-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP6008743B2 (ja) * 2010-03-01 2016-10-19 エムディーエヌエー ライフ サイエンシズ インコーポレイテッド ＵＶに関連するｍｔＤＮＡの融合転写物ならびにその方法および使用
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
IN2012MN02812A (https=) 2010-06-23 2015-05-22 Astute Medical Inc
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
ES2625288T3 (es) 2011-04-15 2017-07-19 The Johns Hopkins University Sistema de secuenciación segura
CA2852665A1 (en) 2011-10-17 2013-04-25 Good Start Genetics, Inc. Analysis methods
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
AU2013292610B2 (en) * 2012-07-17 2018-05-17 Myriad Women's Health, Inc. System and methods for detecting genetic variation
AU2013338393C1 (en) 2012-10-29 2024-07-25 The Johns Hopkins University Papanicolaou test for ovarian and endometrial cancers
US9868946B2 (en) * 2012-11-05 2018-01-16 Icahn School Of Medicine At Mount Sinai Method of isolating pure mitochondrial DNA
ES2482866B1 (es) * 2012-11-22 2015-05-12 Consejo Superior De Investigaciones Científicas (Csic) Método de diagnóstico y/o pronóstico de enfermedades neurodegenerativas.
EP3361255B1 (en) 2013-01-17 2020-03-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2014152421A1 (en) 2013-03-14 2014-09-25 Good Start Genetics, Inc. Methods for analyzing nucleic acids
US8847799B1 (en) 2013-06-03 2014-09-30 Good Start Genetics, Inc. Methods and systems for storing sequence read data
US11041203B2 (en) 2013-10-18 2021-06-22 Molecular Loop Biosolutions, Inc. Methods for assessing a genomic region of a subject
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
US9745611B2 (en) * 2014-05-06 2017-08-29 Genewiz Inc. Methods and kits for identifying microorganisms in a sample
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
CN104062294A (zh) * 2014-07-11 2014-09-24 青岛千士医疗科技有限公司 一种支气管/肺上皮细胞线粒体损伤的检测方法
US20160048608A1 (en) 2014-08-15 2016-02-18 Good Start Genetics, Inc. Systems and methods for genetic analysis
US11408024B2 (en) 2014-09-10 2022-08-09 Molecular Loop Biosciences, Inc. Methods for selectively suppressing non-target sequences
US10429399B2 (en) 2014-09-24 2019-10-01 Good Start Genetics, Inc. Process control for increased robustness of genetic assays
KR20210013299A (ko) 2014-10-17 2021-02-03 코디악 사이언시스 인코포레이티드 부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
EP4095261B1 (en) 2015-01-06 2025-05-28 Molecular Loop Biosciences, Inc. Screening for structural variants
EP3091083B1 (en) 2015-05-07 2017-11-08 Latvian Biomedical Research and Study Centre A kit for detecting mutation or polymorphism in the human mitochondrial dna
JP6841609B2 (ja) 2015-07-10 2021-03-10 ３スキャン インコーポレイテッド 組織学的染色の空間的多重化
US11286531B2 (en) 2015-08-11 2022-03-29 The Johns Hopkins University Assaying ovarian cyst fluid
EP3465201A4 (en) 2016-06-06 2020-08-26 Astute Medical, Inc. MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
IL319255A (en) 2017-08-07 2025-04-01 Univ Johns Hopkins Methods and materials for cancer assessment and treatment
CN108827887B (zh) * 2018-03-19 2021-05-18 陕西学前师范学院 一种商陆基因组大小估计方法及基因组大小测量系统
EP3578671A1 (en) * 2018-06-05 2019-12-11 Universitat Autònoma De Barcelona Method for evaluating risk of cardiovascular disease
CN109360656B (zh) * 2018-08-20 2021-11-02 安徽大学 一种基于多目标演化算法的癌症检测方法
EP3966323A4 (en) * 2019-05-06 2024-04-24 The Regents Of The University Of Michigan TARGETED THERAPY
CN110378881B (zh) * 2019-07-05 2020-03-24 北京航空航天大学 一种基于深度学习的肿瘤定位系统
CN110358856B (zh) * 2019-07-23 2023-04-07 四川省农业科学院生物技术核技术研究所 侧耳属线粒体nad4L基因的扩增引物及其在鉴定侧耳属物种中的应用
CN113025633B (zh) * 2019-12-09 2024-08-27 武汉纽福斯生物科技有限公司 编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
JP2023513606A (ja) 2020-02-14 2023-03-31 ザ・ジョンズ・ホプキンス・ユニバーシティー 核酸を評価するための方法および材料
WO2021248034A2 (en) * 2020-06-04 2021-12-09 The General Hospital Corporation Methods of detecting mitochondrial diseases
CN117070511B (zh) * 2023-08-16 2024-02-02 广州卿泽生物科技有限公司 一种用于扩增人类线粒体全基因组的引物组及其应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020155438A1 (en) * 1998-11-20 2002-10-24 Andrew John George Simpson Method for determining nucleotide sequences using arbitrary primers and low stringency
WO2002101086A2 (en) * 2001-06-11 2002-12-19 1304854 Ontario Ltd. Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
US20050026167A1 (en) * 2001-06-11 2005-02-03 Mark Birch-Machin Complete mitochondrial genome sequences as a diagnostic tool for the health sciences

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2356536A (en) * 1939-07-18 1944-08-22 Rzymkowski Johannes Developing process
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US6027883A (en) 1994-03-30 2000-02-22 Mitokor Optimal procedure for isolation of mutant mitochondrial alleles
US5565323A (en) 1994-03-30 1996-10-15 Mitokor Cytochrome oxidase mutations aiding diagnosis of sporadic alzheimer's disease
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
JPH1099085A (ja) 1996-05-16 1998-04-21 Affymetrix Inc ヒトミトコンドリアｄｎａの多形性
JP3251219B2 (ja) 1997-10-13 2002-01-28 雅嗣 田中 ヒトミトコンドリアｄｎａを用いた遺伝子検出方法
AU773956B2 (en) 1998-08-20 2004-06-10 Johns Hopkins University School Of Medicine, The Subtle mitochondrial mutations as tumor markers
US6605433B1 (en) 1998-08-20 2003-08-12 The Johns Hopkins University Mitochondrial dosimeter
JP2003521879A (ja) 1999-04-20 2003-07-22 マイトコー アルツハイマー病とともに分離するミトコンドリア遺伝子における一塩基多型
SE0003286D0 (sv) 2000-09-15 2000-09-15 Ulf Gyllensten Method and kit for human identification
US20030092019A1 (en) 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia
US20030162174A1 (en) 2001-06-11 2003-08-28 Sutherland John W. Detecting nucleic acid deletion sequences
US20040191769A1 (en) * 2001-07-24 2004-09-30 Transgenomic, Inc. Methods, compositions, and kits for mutation detection in mitochondrial DNA
CA2356536A1 (en) * 2001-08-30 2003-02-28 Emory University Mitochondrial dna sequence alleles
SE0200817D0 (sv) * 2002-03-15 2002-03-15 Ulf Gyllensten Method and kit for detection of mutations in mitochondrial DNA
US20050244851A1 (en) * 2004-01-13 2005-11-03 Affymetrix, Inc. Methods of analysis of alternative splicing in human
CN101248180B (zh) * 2005-04-18 2013-09-25 米托米克斯公司 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020155438A1 (en) * 1998-11-20 2002-10-24 Andrew John George Simpson Method for determining nucleotide sequences using arbitrary primers and low stringency
WO2002101086A2 (en) * 2001-06-11 2002-12-19 1304854 Ontario Ltd. Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
US20050026167A1 (en) * 2001-06-11 2005-02-03 Mark Birch-Machin Complete mitochondrial genome sequences as a diagnostic tool for the health sciences

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Anirban Maitra et al.The Human MitoChip: A High-Throughput Sequencing Microarray for Mitochondrial Mutation Detection.《Genome Research》.2004,第14卷812-819. *
Benjamin C.Jessie et al.Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages.《Experimental Gerontology》.2001,第37卷169-174. *
Carmen Jeronimo et al.Mitochondrial mutations in early stage prostate cancer and bodily fluids.《Oncogene》.2001,第20卷5195-5198. *
John A. Petros et al.mtDNA mutations increase tumorigenicity in prostate cancer.《PNAS》.2005,第102卷(第3期),719-724. *
Junjian Z. Chen et al.Extensive Somatic Mitochondrial Mutations in Primary Prostate Cancer Using Laser Capture Microdissection.《CANCER RESEARCH》.2002,第62卷6470-6474. *
Kim J. Krishnan et al.The Use of a 3895 bp Mitochondrial DNA Deletion as a Marker for Sunlight Exposure in Human Skin.《THE JOURNAL OF INVESTIGATIVE DERMATOLOGY》.2004,第123卷(第6期),1020-1024. *
SE Durham et al.Mitochondrial DNA damage in non-melanoma skin cancer.《British Journal of Cancer》.2003,第88卷(第1期),90-95. *
Valerie Cormier-Daire et al.Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy.《The Journal of Pediatrics》.1994,第124卷(第1期),63-70. *
Weizhu Zhu et al.Large-scale mitochondrial DNA deletion mutations and nuclear genome instability in human breast cancer.《Cancer Detection and Prevention》.2004,第28卷119-126. *

Also Published As

Publication number Publication date
CA2606156A1 (en) 2006-10-26
JP2008536496A (ja) 2008-09-11
EP2339032B1 (en) 2016-12-28
US20090192047A1 (en) 2009-07-30
KR101363032B1 (ko) 2014-02-13
JP5537804B2 (ja) 2014-07-02
JP6134890B2 (ja) 2017-05-31
US20150284805A1 (en) 2015-10-08
US20120058483A1 (en) 2012-03-08
EP1877559B1 (en) 2010-10-13
WO2006111029A1 (en) 2006-10-26
US8008008B2 (en) 2011-08-30
EP1877559A1 (en) 2008-01-16
CN103789405A (zh) 2014-05-14
PT1877559E (pt) 2011-01-19
DK1877559T3 (da) 2011-02-07
CN103789405B (zh) 2018-03-30
EP1877559A4 (en) 2009-06-10
US10907213B2 (en) 2021-02-02
SG2014011837A (en) 2014-04-28
ES2354452T3 (es) 2011-03-15
CA2792443A1 (en) 2006-10-26
NZ562928A (en) 2011-01-28
EP2339032A1 (en) 2011-06-29
JP2012179053A (ja) 2012-09-20
CN101248180A (zh) 2008-08-20
US20180105885A1 (en) 2018-04-19
AU2006238390B2 (en) 2011-07-28
ATE484589T1 (de) 2010-10-15
DE602006017534D1 (de) 2010-11-25
NZ587665A (en) 2011-11-25
KR20080025040A (ko) 2008-03-19
CA2606156C (en) 2013-01-08
US9745632B2 (en) 2017-08-29
AU2006238390A1 (en) 2006-10-26

Similar Documents

Publication Publication Date Title
CN101248180B (zh) 作为检测日光照射、前列腺癌和其它癌症的诊断工具的线粒体突变及重排
US20050026167A1 (en) Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
CN104178487B (zh) Atm基因突变体及其应用
US20070190534A1 (en) Mitochondrial sites and genes associated with prostate cancer
JP2005506057A (ja) 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列
Huijsmans et al. Single nucleotide polymorphism profiling assay to confirm the identity of human tissues
AU2011242123B2 (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
CA2550135A1 (en) Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
CN101871003A (zh) 预测中国人2型糖尿病易感性的试剂盒及引物
HK1159190B (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
HK1159190A (en) Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
AU2002312671A1 (en) Complete mitochondrial genome sequences as a diagnostic tool for the health sciences

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Ryan Parr

Inventor after: Thayer Robert

Inventor after: Gabriel Dokubo

Inventor after: Creed Jennifer

Inventor after: Kerry Robinson

Inventor after: Aguirre Andrea

Inventor after: Reguly Brian

Inventor after: Andre Habotel

Inventor after: Mark Bilk-Makin

Inventor before: Ryan Parr

Inventor before: Thayer Robert

Inventor before: Gabriel Dokubo

Inventor before: Maki Jennifer

Inventor before: Kerry Robinson

Inventor before: Aguirre Andrea

Inventor before: Reguly Brian

Inventor before: Andre Habotel

Inventor before: Mark Bilk-Makin

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM:

TR01 Transfer of patent right

Effective date of registration: 20180104

Address after: Delaware

Patentee after: MDNA Life Sciences Inc.

Address before: Ontario

Patentee before: Mitomics Inc.

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130925

CF01 Termination of patent right due to non-payment of annual fee